市場調査レポート
商品コード
1439261
機械的循環補助装置の世界市場:洞察、競合情勢、市場予測:2030年Mechanical Circulatory Support Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
機械的循環補助装置の世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の機械的循環補助装置の市場規模は2023年に24億7,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.44%のCAGRで拡大し、2030年には42億4,000万米ドルに達すると予測されています。機械的循環補助装置の需要は、主に心血管疾患(CVD)の有病率の上昇、心血管疾患(CVD)の危険因子の増加、製品ポートフォリオにおける技術進歩、心臓ドナーの不足、予測期間中のその他が動機となっています。
米国心臓協会(American Heart Association 2022)によると、2020年には世界で約2億4,410万人が冠動脈(虚血)性心疾患を患っています。同出典によると、北アフリカ、中東、中央・南アジア、中東欧は、2020年に世界で冠動脈(虚血性)心疾患の有病率が最も高くなっています。
英国心臓財団(British Heart Foundation)2022年版のデータによると、2019年には全世界で約5億5,000万人(14人に1人)が心臓・循環器疾患を患っており、この中には約2億9,000万人の女性と約2億6,000万人の男性が含まれています。
肥満、高血圧、糖尿病、喫煙、高齢、飲酒、不健康なライフスタイル、アテローム性動脈硬化症などの危険因子の増加が心血管疾患発症の主な理由であり、機械的循環補助装置の市場成長をさらに促進しています。
WHOのデータ(2023年)によると、2020年には全世界で約10億人が60歳以上でした。60歳以上の高齢者人口は2050年までに倍増し、約21億人に達すると予想されています。また、80歳以上の高齢者は2020年から2050年の間に3倍に増え、4億2,600万人に達すると推定されています。
当レポートでは、世界の機械的循環補助装置市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Mechanical Circulatory Support Devices Market By Product (Ventricular Assist Devices [Left Ventricular Assist Device, Right Ventricular Assist Device, and Biventricular Assist Device], Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pump), End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular diseases
The global mechanical circulatory support devices market was valued at USD 2.47 billion in 2023, growing at a CAGR of 9.44% during the forecast period from 2024 to 2030, to reach USD 4.24 billion by 2030. The demand for mechanical circulatory support devices is primarily motivated by a rise in cardiovascular disease (CVDs) prevalence, an increasing number of risk factors for cardiovascular diseases (CVDs), technological advancements in the product portfolio, scarcity of heart donors, and others during the forecast period.
Mechanical Circulatory Support Devices Market Dynamics:
According to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.
As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.
The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others is the main reason for the development of cardiovascular diseases further driving the market growth for mechanical circulatory support devices.
According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.
However, high treatment costs and limitations regarding the safety of implantable devices may prove to be certain restraints to the mechanical circulatory support devices market growth.
Mechanical Circulatory Support Devices Market Segment Analysis:
Mechanical Circulatory Support Devices by Product (Ventricular Assist Devices [Left Ventricular Assist Device, Right Ventricular Assist Device, and Biventricular Assist Device], Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pump), End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the mechanical circulatory support devices market product segment, under the ventricular assist devices segment, the left ventricular assist device category is expected to hold the largest share and is one of the fastest-growing segments in this market.
This is primarily attributed to technological advancements, the scarcity of organ donors, and the increasing prevalence of heart failure globally. The technologically advanced features like the smaller size enable it to be implanted with minimal invasion to provide complete ventricular circulation assistance and reduced hemolysis by providing ample path for circulation, thus accounting for the largest shareholder in the market.
Mechanical circulatory support (MCS) with left ventricular assist devices (LVAD) is a safe and efficacious treatment strategy for patients with end-stage heart failure (HF) that is refractory to medical therapy, with >22 000 devices implanted to date in America and >2500 new implants occurring annually.
Technological advances in left ventricular assist devices (LVAD), including continuous flow technology, have aided in improving implantability and efficiency; providing extended support helps in creating demand for these devices, thereby contributing to the growth of the mechanical circulatory support devices market.
Additionally, assistance from government bodies, and favorable reimbursement scenarios, are expected to enhance the mechanical circulatory support devices market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.
North America is expected to dominate the Overall Mechanical Circulatory Support Devices Market:
North America is expected to dominate the overall Mechanical Circulatory Support Devices market during the forecast period. This domination is due to the growing prevalence of chronic diseases in the region, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others.
For instance, the American Heart Association in 2021 projected that by 2035, more than 130 million US adults will have some type of heart disease.
According to the Centers for Disease Control and Prevention (CDC) 2022, around 18.2 million people aged 20 or above have coronary artery disease in the US.
As per the above-mentioned source, around 805,000 people face heart attacks every year with 605,000 people facing it for the first time and about 200,000 having at least one incident of a heart attack before.
Thus, the increasing prevalence of various cardiovascular diseases will increase the demand for mechanical circulatory support devices in the North American region, during the forecast period from 2024-2030.
Mechanical Circulatory Support Devices Market Key Players:
Some of the key market players operating in the mechanical circulatory support devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.
Recent Developmental Activities in the Mechanical Circulatory Support Devices Market:
In October 2020, the US Food and Drug Administration (FDA) granted 510(k) clearance to Abiomed for an all-in-one, compact extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System.
Key Takeaways from the Mechanical Circulatory Support Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global mechanical circulatory support devices market.
Various opportunities are available for the other competitor in the mechanical circulatory support devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for mechanical circulatory support devices market growth in the coming future?
Target Audience who can be benefited from this Mechanical Circulatory Support Devices Market Report Study
Mechanical Circulatory Support Devices providers
Research organizations and consulting companies
Mechanical Circulatory Support Devices related to organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in mechanical circulatory support devices
Various End-Users want to know more about the mechanical circulatory support devices market and the latest technological developments in the mechanical circulatory support devices market.
Frequently Asked Questions for Mechanical Circulatory Support Devices Market:
Mechanical Circulatory Support Devices are devices that replace or assist the pumping function of the ventricles. These devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy.
The global mechanical circulatory support devices market was valued at USD 2.47 billion in 2023, growing at a CAGR of 9.44% during the forecast period from 2024 to 2030, to reach USD 4.24 billion by 2030.
The major drivers driving the demand for mechanical circulatory support devices are rising technological advancement, the growing burden of cardiovascular diseases, and the increasing geriatric population.
Some of the key market players operating in the mechanical circulatory support devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.
North America is expected to dominate the overall mechanical circulatory support devices market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in mechanical circulatory support devices, and the increasing chronic disease in the region.